Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

SE Nissen, T Tsunoda, EM Tuzcu, P Schoenhagen… - Jama, 2003 - jamanetwork.com
Context Although low levels of high-density lipoprotein cholesterol (HDL-C) increase risk for
coronary disease, no data exist regarding potential benefits of administration of HDL-C or an …

[PDF][PDF] Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

SE Nissen, T Tsunoda, EM Tuzcu, P Schoenhagen… - JAMA, 2003 - researchgate.net
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute
Coronary Syndromes Page 1 PRELIMINARY COMMUNICATION Effect of Recombinant ApoA-I …

[PDF][PDF] Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

SE Nissen, T Tsunoda, EM Tuzcu, P Schoenhagen… - JAMA, 2003 - academia.edu
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute
Coronary Syndromes: A Randomized Controll Page 1 PRELIMINARY COMMUNICATION …

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes: A Randomized Controlled Trial.

SE Nissen, T Tsunoda, EM Tuzcu… - JAMA: Journal of …, 2003 - search.ebscohost.com
Context: Although low levels of high-density lipoprotein cholesterol (HDL-C) increase risk for
coronary disease, no data exist regarding potential benefits of administration of HDL-C or an …

[PDF][PDF] Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

SE Nissen, T Tsunoda, EM Tuzcu… - …, 2003 - misc.biblio.s3.amazonaws.com
Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute
Coronary Syndromes Page 1 PRELIMINARY COMMUNICATION Effect of Recombinant ApoA-I …

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

SE Nissen, T Tsunoda, EM Tuzcu, P Schoenhagen… - JAMA, 2003 - europepmc.org
Objective We assessed the effect of intravenous recombinant ApoA-I Milano/phospholipid
complexes (ETC-216) on atheroma burden in patients with acute coronary syndromes …

[引用][C] Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

N SE - JAMA, 2003 - cir.nii.ac.jp
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute
coronary syndromes : a randomized controlled trial | CiNii Research CiNii 国立情報学研究所 …

[引用][C] Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial

SE NISSEN, T TSUNODA, S HALPERN… - JAMA, the journal of …, 2003 - pascal-francis.inist.fr
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute
coronary syndromes: A randomized controlled trial CNRS Inist Pascal-Francis CNRS …

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial

SE Nissen, T Tsunoda, EM Tuzcu, P Schoenhagen - JAMA, 2003 - elibrary.ru
Nissen et al assess the effect of intravenous recombinant ApoA-I Milano/phospholipid
complexes (ETC-216) on atheroma burden in patients with acute coronary syndromes. A …